Health
Moffitt researchers reveal why some ovarian cancer patients evolve better than others – News-Medical.Net
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed….
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed. These poor outcomes are partly due to the lack of effective therapies for advanced disease and recurrence. Immunotherapies hold promise for many types of cancer; however, studies have shown that patients with ovarian cancer do not have strong responses to existing drugs.
In a new article published in Nature, Moffitt Cancer Center…
-
Noosa News22 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General23 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News21 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
Noosa News20 hours agoMissing man, Maroochydore – Queensland Police News